Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Combination Chemotherapy in Young Children With Non-metastatic Nodular Desmoplastic Medulloblastoma
NCT02017964Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Dec 2013
- Primary completion
- Mar 2018
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Lipid-based Nanoparticles
- Countries
- 4
01
Overview
A Phase 2 trial of vincristine sulfate liposome injection, cyclophosphamide, methotrexate, etoposide, carboplatin in medulloblastoma, sponsored by Children's Oncology Group. Started Dec 2013; status: completed.
02
Drugs
vincristine sulfate liposome injectioncyclophosphamidemethotrexateetoposidecarboplatin
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT02017964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017964.